Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Single Nucleotide Polymorphisms of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects: A Phase II, Multicenter, Double-blind Study

NCT02777489 is registered in ClinicalTrials.gov with Gene PreDiT as lead sponsor.

NCT NCT02777489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02777489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Single Nucleotide Polymorphisms of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects: A Phase II, Multicenter, Double-blind Study
Lead sponsor
Gene PreDiT
Phase
Phase 2
Overall status
Terminated
Start date
February 18, 2016
Completion date
April 27, 2017
Enrollment
140 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

obesity